Sort
30,917 grants matching “tumor microenvironment”
Roles of miR-129 in colorecal cancer
$359,202Jingfang Ju · State University New York Stony Brook · R01 · FY2020 · CA
Roles of miR-129 in colorecal cancer
$359,202Jingfang Ju · State University New York Stony Brook · R01 · FY2016 · CA
Roles of miR-129 in colorecal cancer
$359,202Jingfang Ju · State University New York Stony Brook · R01 · FY2017 · CA
Targeting macrophages in metastatic cancer
$359,162Anthony Rongvaux · Fred Hutchinson Cancer Center · R01 · FY2022 · CA
A preclinical integrated PET/EPR imaging system
$359,144Chien-Min Kao · University Of Chicago · R01 · FY2022 · EB
Influence of hemodynamic shear stress on circulating tumor cells
$359,143Michael D. Henry · University Of Iowa · R01 · FY2023 · CA
A preclinical integrated PET/EPR imaging system
$359,143Chien-Min Kao · University Of Chicago · R01 · FY2023 · EB
Tumor-Targeted Chemo-Immunotherapy for Osteosarcoma Metastasis
$359,138Liangfang Zhang · University Of California, San Diego · R01 · FY2018 · CA
Ethnicity-determined T cell responses and GARP/TGFbeta1 signaling in prostate cancer
$359,138Xiaolin Zi · University Of California-Irvine · R01 · FY2025 · CA
Stimuli-responsive crosslinked theranostics against advanced prostate cancer
$359,138Yuanpei Li · University Of California At Davis · R01 · FY2017 · CA
Stimuli-responsive crosslinked theranostics against advanced prostate cancer
$359,138Yuanpei Li · University Of California At Davis · R01 · FY2018 · CA
Tumor-Targeted Chemo-Immunotherapy for Osteosarcoma Metastasis
$359,138Liangfang Zhang · University Of California, San Diego · R01 · FY2017 · CA
Stimuli-responsive crosslinked theranostics against advanced prostate cancer
$359,138Yuanpei Li · University Of California At Davis · R01 · FY2016 · CA
Tumor-Targeted Chemo-Immunotherapy for Osteosarcoma Metastasis
$359,138Liangfang Zhang · University Of California, San Diego · R01 · FY2020 · CA
Project 3: The Role of Macrophages in Resistance to Anti-VEGF Drugs in Ovarian Cancer
$359,129Anil K Sood · University Of Tx Md Anderson Can Ctr · P50 · FY2020 · CA
Stimulating Lymphocyte Activation Combined with Inhibition of Immunosuppressive Signals in Colon Cancer Metastases
$359,032Ajay V. Maker · University Of California, San Francisco · R37 · FY2024 · CA
Bone-Targeted Therapies to Improve Bone Health and Prevent Relapse in Multiple Myeloma
$358,966Jesus Delgado-Calle · Univ Of Arkansas For Med Scis · R37 · FY2020 · CA
Roles of inflammation-driven chemokines in the pathogenesis of ovarian cancer
$358,962Deok-Soo Son · Meharry Medical College · SC1 · FY2012 · AI
Roles of inflammation-driven chemokines in the pathogenesis of ovarian cancer
$358,962Deok-Soo Son · Meharry Medical College · SC1 · FY2011 · AI
Tailoring AAV Vectors for Glioma Immunotherapy
$358,962Ou Cao · University Of Florida · R01 · FY2011 · AI
Sphingosine-1-Phosphate Pathway Based Therapy for Neuroblastoma
$358,902Fernando Anthony Ferrer · University Of Connecticut Sch Of Med/Dnt · R01 · FY2012 · CA
Mechanisms of Immune Modulation Mediated by Yeast-derived Particulate Beta-Glucan
$358,900Jun Yan · University Of Louisville · R01 · FY2011 · CA
Mechanisms of Immune Modulation Mediated by Yeast-derived Particulate Beta-Glucan
$358,900Jun Yan · University Of Louisville · R01 · FY2012 · CA
Mechanisms of neuroinflammation in brain metastasis progression
$358,895Siyuan Zhang · University Of Notre Dame · R01 · FY2019 · CA
Engineer Biomimetic Microfluidic Models to Investigate and Reprogram Tumor Associated Neutrophils for Cancer Therapy
$358,885Xiaoping Bao · Purdue University · R37 · FY2022 · CA